Back to top
more

ARK Genomic Revolution ETF: (ARKG)

(Delayed Data from NYSE MKT (ex. AMEX)) As of Jul 30, 2024 04:00 PM ET

$26.74 USD

26.735
1,731,512

-0.17 (-0.61%)

Volume: 1,731,512

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $26.49 -0.25 (-0.92 %) 7:58 PM ET

Zacks News

Sanghamitra Saha headshot

Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks

Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.

Sweta Killa headshot

S&P 500 at Record High: 6 ETF Winners of Last Week

The S&P 500 hit record highs last week, with the index rising for the fourth consecutive week, marking its longest winning streak since March.

Panel Of Zacks Experts headshot

Navigating The Healthcare Industry: Science Fiction Turns to Reality

Kevin Cook joins us to help walk us through the maze that is the healthcare industry. We touch on everything from the hottest trends all the way down to how to pick a winning stock!

Sanghamitra Saha headshot

Tap Revenue Growth With These ETFs & Dump Earnings Recession

These sector ETFs could be played to highlight revenue growth in the third quarter.

Sweta Jaiswal, FRM headshot

ETFs Poised to Benefit from Gene Editing Revolution

Rising investments and growing technological advancement are favoring the genomic editing space. We take a look at a few ETFs that can cash in on this trend.

Sweta Jaiswal, FRM headshot

ETFs to Gain From the Booming Genomics Market

Rising investments, surging demand for personalized medicines and shrinking sequencing costs are a slew of factors favouring the genomics space. We look at a few ETFs that can cash in on this trend.

Sweta Jaiswal, FRM headshot

Top-Performing Biotech ETFs YTD

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to boost the biotech stocks. Accordingly, we take a look at biotech ETFs gaining more than 10% year to date.

Sweta Killa headshot

5 U.S. ETFs Seeing Fireworks Ahead of July Fourth

These ETFs focus exclusively on U.S. equities and deserve the attention of investors seeking a domestic tilt to their portfolio ahead of the Jul 4 holiday.

Sweta Killa headshot

5 Sector ETFs That Beat the Market in the First Half

With just a trading session left to end the first half, the Dow Jones is up about 13.7% while the S&P 500 and Nasdaq have gained 16.7% and 20.1%, respectively.

Neena Mishra headshot

Why These Innovative Biotech ETFs Are Soaring

Strong M&A activity has sent shares of many small, innovative biotech companies surging

Sweta Killa headshot

S&P 500 Hits New High: 10 Top-Performing ETFs YTD

Braving global growth concerns, the bulls are back with the S&P 500 surging to its first record close since April.

Sweta Killa headshot

Pfizer-Array Biopharma Deal Bump Up Biotech ETFs

Pfizer struck a deal to acquire the cancer drugmaker Array Biopharma for $11 billion in an all-cash consideration.

Sweta Killa headshot

ETF Winners & Losers As China Retaliates

The renewed trade spat has led to just a few winners but a number of losers from various corners of the investing space.

Sanghamitra Saha headshot

Forget Earnings Recession: Tap Revenue Growth With These ETFs

First-quarter earnings growth is likely to be negative this year, but revenues will grow. So, play revenue growth with these sector ETFs.

Sweta Jaiswal, FRM headshot

Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

Sweta Jaiswal, FRM headshot

Global X Launches GNOM ETF to Tap Booming Genomics Space

Having exposure to trending areas like Robotics & AI, e-commerce and IoT, Global X is set to gain from the booming genomics market with the GNOM ETF.

Neena Mishra headshot

Best Performing ETFs of the First Quarter

Major indexes posted their best quarterly performance since the financial crisis; here are some ETFs that soared during the quarter

Sweta Killa headshot

ETFs That Topped & Flopped in Q1

We have highlighted both the best and worst performing ETFs of Q1 from different zones or industries.

Sweta Killa headshot

4 Market-Beating Sector ETFs of the First Quarter

We have highlighted four sector ETFs that have been the quarter's star performers and could also be winners next quarter if the current trends continue.

Sweta Killa headshot

4 Best-Performing Sector ETFs of March

A few sector ETFs have easily outperformed the market and are trading in the green this month.

Sanghamitra Saha headshot

Best & Worst ETFs of Last Week

Inside the top-and-under-performing ETFs of last week.

Sweta Killa headshot

4 Best-Performing Sector ETFs of February

We have highlighted four sectors ETFs that have gained double-digits in February and could be better plays in the months ahead.

Sweta Killa headshot

Biotech ETFs Jump on Roche-Spark Deal

The news of Roche-Spark Deal has triggered speculations of merger wave in the gene therapy industry and pushed the biotech ETFs higher.

Sweta Killa headshot

Best & Worst Performing ETFs to Start 2019

We have highlighted some ETFs that are off to a good start in 2019 and some that have had a rough start.

Sweta Killa headshot

Top & Flop Zones of Q3 & Their ETFs

Some corners of ETF investing have performed exceptionally well in the third quarter while some are lagging.